Drug Profile
Trovafloxacin
Alternative Names: CP-99,219; Trovafloxacin mesylate; Trovan; TurvelLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antibacterials; Fluoroquinolones; Naphthyridines
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bacterial infections; Genital tract infections
- Market Withdrawal Respiratory tract infections
- Discontinued Toxoplasmosis
Most Recent Events
- 20 Mar 2001 The European Commission has formally withdrawn the marketing authorisations in the European Union for trovafloxacin and alatrofloxacin
- 20 Mar 2001 Withdrawn for Bacterial infections in European Union (PO), including Austria, Denmark, Finland, The Netherlands, Portugal and Sweden
- 20 Mar 2001 Withdrawn for Bacterial infections in Germany (PO)